Noncompetitive Allosteric Antagonism of Death Receptor 5 by a Synthetic Affibody Ligand.


Journal

Biochemistry
ISSN: 1520-4995
Titre abrégé: Biochemistry
Pays: United States
ID NLM: 0370623

Informations de publication

Date de publication:
13 10 2020
Historique:
pubmed: 18 9 2020
medline: 23 3 2021
entrez: 17 9 2020
Statut: ppublish

Résumé

Fatty acid-induced upregulation of death receptor 5 (DR5) and its cognate ligand, tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), promotes hepatocyte lipoapoptosis, which is a key mechanism in the progression of fatty liver disease. Accordingly, inhibition of DR5 signaling represents an attractive strategy for treating fatty liver disease. Ligand competition strategies are prevalent in tumor necrosis factor receptor antagonism, but recent studies have suggested that noncompetitive inhibition through perturbation of the receptor conformation may be a compelling alternative. To this end, we used yeast display and a designed combinatorial library to identify a synthetic 58-amino acid affibody ligand that specifically binds DR5. Biophysical and biochemical studies show that the affibody neither blocks TRAIL binding nor prevents the receptor-receptor interaction. Live-cell fluorescence lifetime measurements indicate that the affibody induces a conformational change in transmembrane dimers of DR5 and favors an inactive state of the receptor. The affibody inhibits apoptosis in TRAIL-treated Huh-7 cells, an

Identifiants

pubmed: 32941010
doi: 10.1021/acs.biochem.0c00529
pmc: PMC7658720
mid: NIHMS1643723
doi:

Substances chimiques

Ligands 0
Peptides 0
Receptors, TNF-Related Apoptosis-Inducing Ligand 0
TNF-Related Apoptosis-Inducing Ligand 0
TNFRSF10B protein, human 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

3856-3868

Subventions

Organisme : NIAID NIH HHS
ID : R21 AI144932
Pays : United States
Organisme : NIBIB NIH HHS
ID : R01 EB028274
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK041876
Pays : United States
Organisme : NIBIB NIH HHS
ID : R01 EB023339
Pays : United States
Organisme : NIGMS NIH HHS
ID : R35 GM131814
Pays : United States

Références

Hepatol Commun. 2017 Sep;1(7):648-662
pubmed: 29124251
Biochim Biophys Acta Biomembr. 2017 Sep;1859(9 Pt A):1398-1416
pubmed: 28089689
Mayo Clin Proc. 2001 Jun;76(6):653-6
pubmed: 11393506
BioDrugs. 2007;21(1):23-9
pubmed: 17263587
Arthritis Rheum. 2010 Aug;62(8):2424-31
pubmed: 20506390
Histochem Cell Biol. 2014 Jul;142(1):91-101
pubmed: 24519400
Molecules. 2011 Mar 14;16(3):2467-85
pubmed: 21407148
Nature. 2012 Aug 23;488(7412):508-511
pubmed: 22801493
Inflamm Bowel Dis. 2001 Nov;7(4):327
pubmed: 11720324
Rheumatology (Oxford). 2002 Mar;41(3):329-37
pubmed: 11934972
J Exp Med. 1992 Feb 1;175(2):323-9
pubmed: 1310100
J Mol Biol. 2017 Sep 15;429(19):2943-2953
pubmed: 28834692
Nat Med. 2005 Oct;11(10):1066-72
pubmed: 16170321
N Engl J Med. 2000 Mar 16;342(11):810-1
pubmed: 10717018
J Hepatol. 2015 May;62(5):1156-63
pubmed: 25445398
Biotechnol Appl Biochem. 2009 Aug 17;54(2):93-103
pubmed: 19545237
Science. 1997 Aug 8;277(5327):815-8
pubmed: 9242610
Nat Commun. 2019 Dec 19;10(1):5795
pubmed: 31857588
J Biol Chem. 2011 Nov 11;286(45):39336-48
pubmed: 21941003
PLoS One. 2015 Dec 04;10(12):e0144295
pubmed: 26636761
Cold Spring Harb Perspect Biol. 2013 May 01;5(5):a008698
pubmed: 23637280
Science. 2000 Jun 30;288(5475):2351-4
pubmed: 10875917
J Biol Chem. 1995 Jun 2;270(22):13303-7
pubmed: 7768931
Protein Eng. 1995 Jun;8(6):601-8
pubmed: 8532685
FEBS Lett. 2005 Sep 26;579(23):5193-8
pubmed: 16162344
Br J Pharmacol. 2008 Mar;153 Suppl 1:S358-66
pubmed: 18059316
Biochemistry. 2012 Aug 21;51(33):6545-55
pubmed: 22799488
PLoS One. 2013 Jul 22;8(7):e70599
pubmed: 23894677
J Biol Chem. 2014 May 2;289(18):12457-66
pubmed: 24634219
FEBS J. 2008 Jun;275(11):2668-76
pubmed: 18435759
J Clin Invest. 1999 Jul;104(2):155-62
pubmed: 10411544
Nat Biotechnol. 1997 Aug;15(8):772-7
pubmed: 9255793
J Mol Biol. 2008 Sep 19;381(5):1238-52
pubmed: 18602401
J Mol Biol. 2016 Dec 4;428(24 Pt A):4843-4855
pubmed: 27720987
J Biotechnol. 2007 Jan 30;128(1):162-83
pubmed: 17088007
Future Med Chem. 2013 Jan;5(1):69-79
pubmed: 23256814
Science. 1997 Apr 4;276(5309):111-3
pubmed: 9082980
Nat Med. 1999 Feb;5(2):157-63
pubmed: 9930862
Biochem Biophys Res Commun. 2005 May 20;330(4):1205-12
pubmed: 15823571
Ann Rheum Dis. 2000 Nov;59 Suppl 1:i50-3
pubmed: 11053089
Sci Signal. 2019 Jul 30;12(592):
pubmed: 31363069
Cancer Res. 2006 Apr 15;66(8):4339-48
pubmed: 16618759
Arch Physiol Biochem. 2019 May;125(2):142-149
pubmed: 29463133
Clin Exp Rheumatol. 2003 Mar-Apr;21(2):276-7
pubmed: 12747299
Science. 2000 Jun 30;288(5475):2354-7
pubmed: 10875918
J Biol Chem. 2015 Oct 30;290(44):26457-70
pubmed: 26296891
Clin Lipidol. 2010 Feb 1;5(1):71-85
pubmed: 20368747
J Biol Chem. 2001 Mar 23;276(12):9279-90
pubmed: 11118431
J Immunol. 1993 Aug 1;151(3):1548-61
pubmed: 8393046
J Autoimmun. 2011 Nov;37(3):160-70
pubmed: 21689905
Hepatology. 2009 Nov;50(5):1421-30
pubmed: 19676126
Biochemistry. 2017 Mar 21;56(11):1656-1671
pubmed: 28248518
Clin Immunol. 2008 Jan;126(1):13-30
pubmed: 17916445
J Hepatol. 2010 Sep;53(3):542-50
pubmed: 20557969
J Biol Chem. 1999 Mar 12;274(11):7245-52
pubmed: 10066786
Arthritis Rheum. 1993 Dec;36(12):1681-90
pubmed: 8250987
Biophys J. 2017 Jul 25;113(2):381-392
pubmed: 28746849
J Am Acad Dermatol. 2001 Dec;45(6):953-6
pubmed: 11712048
Clin Cancer Res. 2011 Jan 15;17(2):363-71
pubmed: 21224368
Cell Mol Gastroenterol Hepatol. 2015 Jan;1(1):17-27
pubmed: 25729762
Arthritis Rheum. 2004 Jun;50(6):1740-51
pubmed: 15188349
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2012 Aug 1;68(Pt 8):878-82
pubmed: 22869113
J Biol Chem. 2006 Apr 28;281(17):12093-101
pubmed: 16505490
Proc Natl Acad Sci U S A. 1996 Jan 23;93(2):654-8
pubmed: 8570610
J Biol Chem. 2012 Jun 15;287(25):21265-78
pubmed: 22496450
Proc Natl Acad Sci U S A. 2005 Dec 13;102(50):18099-104
pubmed: 16319225
J Biol Chem. 1999 Dec 31;274(53):38241-50
pubmed: 10608899
Biophys J. 2014 Mar 18;106(6):L21-4
pubmed: 24655519
J Mol Biol. 2013 Jan 23;425(2):444-56
pubmed: 23159556
FEBS Lett. 2010 Jun 18;584(12):2670-80
pubmed: 20388508
Science. 1998 Aug 28;281(5381):1305-8
pubmed: 9721089
Cell. 2001 Feb 23;104(4):487-501
pubmed: 11239407
J Biol Chem. 2014 Jun 6;289(23):16576-87
pubmed: 24764293
Immunity. 2000 Jun;12(6):611-20
pubmed: 10894161
J Lipid Res. 2016 Oct;57(10):1758-1770
pubmed: 27049024
Protein Sci. 2013 Apr;22(4):510-5
pubmed: 23389845
Korean J Intern Med. 2007 Mar;22(1):63-6
pubmed: 17427651
Curr Dir Autoimmun. 2010;11:1-26
pubmed: 20173385
Recent Pat Inflamm Allergy Drug Discov. 2010 Nov;4(3):193-200
pubmed: 20807193
Immunity. 2000 Oct;13(4):419-22
pubmed: 11070160
Immunity. 1995 Dec;3(6):673-82
pubmed: 8777713
SLAS Discov. 2017 Sep;22(8):950-961
pubmed: 28530838
Lancet. 2002 Feb 16;359(9306):579-80
pubmed: 11867114
J Mol Biol. 2004 Sep 10;342(2):539-50
pubmed: 15327953
Nat Chem Biol. 2016 Oct;12(10):860-6
pubmed: 27547920
Protein Eng Des Sel. 2008 Apr;21(4):247-55
pubmed: 18239074
ACS Comb Sci. 2019 Mar 11;21(3):207-222
pubmed: 30620189

Auteurs

Nagamani Vunnam (N)

Department of Biomedical Engineering, University of Minnesota, Minneapolis, Minnesota 55455, United States.

Sophia Szymonski (S)

Department of Biomedical Engineering, University of Minnesota, Minneapolis, Minnesota 55455, United States.

Petra Hirsova (P)

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota 55905, United States.

Gregory J Gores (GJ)

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota 55905, United States.

Jonathan N Sachs (JN)

Department of Biomedical Engineering, University of Minnesota, Minneapolis, Minnesota 55455, United States.

Benjamin J Hackel (BJ)

Department of Chemical Engineering and Materials Science, University of Minnesota, Minneapolis, Minnesota 55455, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH